ProfileGDS4718 / 215560_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 50% 38% 45% 43% 42% 35% 40% 41% 41% 42% 48% 37% 39% 39% 42% 39% 42% 38% 52% 41% 42% 40% 44% 45% 38% 45% 47% 49% 43% 39% 38% 42% 39% 38% 37% 43% 42% 43% 45% 41% 41% 40% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2181844
GSM549102patient 115, normal, homogenized [OPG study]5.530350
GSM549104patient 119, normal, homogenized [OPG study]4.8976938
GSM549108patient 138, normal, homogenized [OPG study]5.3082645
GSM549119patient 077, normal, homogenized [OPG study]5.1339143
GSM549133patient 032, cancer, homogenized [OPG study]5.0078942
GSM549139patient 042, cancer, homogenized [OPG study]4.7614735
GSM549099patient 107, normal, homogenized [OPG study]5.0083340
GSM549109patient 139, normal, homogenized [OPG study]5.0663341
GSM549110patient 046, normal, homogenized [OPG study]5.0483141
GSM549114patient 063, normal, homogenized [OPG study]5.0618442
GSM549122patient 082, normal, homogenized [OPG study]5.4033448
GSM549134patient 033, cancer, homogenized [OPG study]4.844937
GSM549136patient 036, cancer, homogenized [OPG study]4.8631939
GSM549140patient 044, cancer, homogenized [OPG study]4.9034639
GSM549111patient 047, normal, homogenized [OPG study]5.0776842
GSM549113patient 057, normal, homogenized [OPG study]4.887639
GSM549132patient 031, cancer, homogenized [OPG study]5.0910842
GSM549137patient 038, cancer, homogenized [OPG study]4.8554538
GSM549142patient 047, cancer, homogenized [OPG study]5.7398752
GSM549100patient 110, normal, homogenized [OPG study]5.0437741
GSM549107patient 135, normal, homogenized [OPG study]5.0641642
GSM549115patient 068, normal, homogenized [OPG study]4.9526140
GSM549116patient 072, normal, homogenized [OPG study]5.1504144
GSM549120patient 078, normal, homogenized [OPG study]5.2485845
GSM549131patient 030, cancer, homogenized [OPG study]4.8422338
GSM549118patient 074, normal, homogenized [OPG study]5.2573745
GSM549129patient 027, cancer, homogenized [OPG study]5.3603447
GSM549123patient 088, normal, homogenized [OPG study]5.4516649
GSM549124patient 006, cancer, homogenized [OPG study]5.195443
GSM549126patient 015, cancer, homogenized [OPG study]4.9317439
GSM549128patient 025, cancer, homogenized [OPG study]4.8762138
GSM549103patient 117, normal, homogenized [OPG study]5.131642
GSM549117patient 073, normal, homogenized [OPG study]4.8920139
GSM549138patient 041, cancer, homogenized [OPG study]4.8780838
GSM549141patient 045, cancer, homogenized [OPG study]4.8040537
GSM549130patient 028, cancer, homogenized [OPG study]5.1288443
GSM549101patient 111, normal, homogenized [OPG study]5.1233442
GSM549105patient 128, normal, homogenized [OPG study]5.1590743
GSM549106patient 134, normal, homogenized [OPG study]5.1917945
GSM549112patient 048, normal, homogenized [OPG study]5.0256941
GSM549125patient 011, cancer, homogenized [OPG study]5.0705341
GSM549127patient 024, cancer, homogenized [OPG study]4.989240
GSM549135patient 035, cancer, homogenized [OPG study]4.9818741